BioNxt Solutions Provides Bi-Weekly MCTO Status Report
VANCOUVER, BC / ACCESS Newswire / June 12, 2025 / BioNxt Solutions Inc. ('BioNxt' or the 'Company') (CSE:BNXT)(OTC PINK:BNXTF)(FSE:4XT), announces that, further to its news release dated May 1, 2025 (the 'Default Announcement'), the Company's principal regulator, the British Columbia Securities Commission (the 'BCSC') granted a management cease trade order (the 'MCTO') on May 1, 2025, under National Policy 12-203 Management Cease Trade Orders ('NP 12-203").
Pursuant to the MCTO, the Chief Executive Officer and the Chief Financial Officer may not trade in securities of the Company until such time as the Company files its annual audited financial statements for the year ended December 31, 2024, including the related management's discussion and analysis, and CEO and CFO certifications on or before June 30, 2025 (collectively the 'Required Documents') and the Executive Director of the BCSC revokes the MCTO. The MCTO does not affect the ability of shareholders to trade their securities.
The Company's staff are working diligently with its auditors and the Company anticipates that it will be in a position to file the Required Documents by June 30, 2025. All previously outstanding audit materials related to the Company's German subsidiaries are now in-hand and the consolidations model is complete. Draft financials have been prepared and provided to the Company's audit firm.
The Company's Board of Directors and management confirm that they are working expeditiously to file the Required Documents and confirm that since the Company's Default Announcement:
Until the Required Documents have been filed, the Company intends to continue to satisfy the provisions of the Alternative Information Guidelines specified in NP 12-203 by issuing these bi-weekly default status reports in the form of further press releases for so long as the Company remains in default of the Required Documents filing requirement.
About BioNxt Solutions Inc.
BioNxt Solutions Inc. is a bioscience innovator focused on next‐generation drug delivery technologies, diagnostic screening systems, and active pharmaceutical ingredient development. The Company's proprietary platforms-Sublingual (Thin‐Film), Transdermal (Skin Patch), and Oral (Enteric‐Coated Tablets)-target key therapeutic areas, including autoimmune diseases, neurological disorders, and longevity.
With research and development operations in North America and Europe, BioNxt is advancing regulatory approvals and commercialization efforts, primarily focused on European markets. BioNxt is committed to improving healthcare by delivering precise, patient‐centric solutions that enhance treatment outcomes worldwide.
BioNxt is listed on the Canadian Securities Exchange: BNXT, OTC Markets: BNXTF and trades in Germany under WKN: A3D1K3. To learn more about BioNxt, please visit www.bionxt.com.
Investor Relations & Media Contact
Hugh Rogers, Co‐Founder, CEO and Director
Email: [email protected]
Phone: +1 778.598.2698
Web: www.bionxt.com
LinkedIn: https://www.linkedin.com/company/bionxt-solutions
Instagram: https://www.instagram.com/bionxt
Cautionary Statement Regarding 'Forward‐Looking' Information
This news release contains forward-looking statements within the meaning of applicable Canadian securities laws. Forward-looking statements are often identified by words such as 'expects,' 'intends,' 'anticipates,' 'believes,' 'estimates,' 'may,' 'could,' 'will,' 'plans,' and similar expressions. These statements relate to future events or future performance, including, but not limited to, statements regarding the anticipated timing for filing the Required Documents, the Company's ability to remedy its filing default, the expected revocation of the MCTO, and the Company's continued compliance with National Policy 12-203 Management Cease Trade Orders ('NP 12-203"). Forward-looking statements are based on the Company's current expectations, beliefs, and assumptions, including assumptions regarding the timely completion of the audit process, the ability of the Company and its auditors to meet required filing deadlines, the accuracy of management's estimates and expectations, regulatory approvals, and market conditions. These statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied in such statements. Factors that could cause actual results to differ materially include, but are not limited to: delays in the audit process; the Company's inability to file the Required Documents within the anticipated timeframe; regulatory or compliance issues; changes in financial reporting or disclosure standards; unanticipated requests for additional information from auditors or regulators; and other unforeseen financial, operational, or regulatory developments. Additional risk factors are outlined in the Company's public filings available on SEDAR+ ( www.sedarplus.ca ). The Company undertakes no obligation to update or revise any forward-looking statements to reflect new information, future events, or otherwise, except as required by law. Investors are cautioned not to place undue reliance on forward-looking statements, as actual results may differ materially from expectations.
SOURCE: BioNxt Solutions Inc.
press release
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Tenet Provides Update on Delayed Filing of Year-End 2024 Financial Results
Toronto, Ontario--(Newsfile Corp. - June 13, 2025) - Tenet Fintech Group Inc. (CSE: PKK) (OTCQB: PKKFF) ("Tenet" or the "Company"), an innovative analytics service provider, owner and operator of the Cubeler® Business Hub, today announced that completing the audit of the Company's year-end 2024 financial statements (the "Financial Statements") would take longer than originally expected, in part due to the transition of the Company's operations in China and the impact on the Company's revenue, and the late start to the audit process affecting the availability of resources. The Company has now set the week of July 14, 2025 as the revised target date to complete the audit and filing of the Financial Statements following a recent meeting with the Company's auditors during which the matter was discussed. Upcoming Cubeler Business Hub Improvements Tenet would like to take this opportunity to thank all Cubeler Business Hub users who have provided, and continue to provide, feedback on their experiences with the platform. The information has been extremely valuable to the Company and has led to several improvements, particularly to the Networking and Insights modules, to be reflected in a relaunch of the platform this summer before its expansion to the United States. Tenet Chief Operating Officer, Mayco Quiroz, will be previewing some of the platform's new and improved features in a short recorded video to be released on June 20, 2025. About Tenet Fintech Group Inc.: Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial intelligence (AI) companies. All references to Tenet in this news release, unless explicitly specified, include Tenet and all its subsidiaries. Tenet's subsidiaries offer various analytics and AI-based products and services to businesses, capital markets professionals, government agencies and financial institutions either through or leveraging data gathered by the Cubeler® Business Hub, a global ecosystem where analytics and AI are used to create opportunities and facilitate B2B transactions among its members. Please visit our website at: For more information, please contact: Tenet Fintech Group Quiroz, Chief Operating Officer514-340-7775 ext.: 510investors@ CHF Capital MarketsCathy Hume, CEO416-868-1079 ext.: 251cathy@ Follow Tenet Fintech Group Inc. on social media: X: @Tenet_Fintech Facebook: @Tenet LinkedIn: Tenet YouTube: Tenet Fintech Forward-Looking Information Certain statements in this press release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements are not guarantees of future performance and involve risks, uncertainties and other factors which may cause actual results, performance or achievements of Tenet to be materially different from the outlook or any future results, performance or achievements implied by such statements. Accordingly, readers are advised not to place undue reliance on forward-looking statements. Important risk factors that could affect the forward-looking statements in this news release include, but are not limited to, holding company with significant operations in China; general economic and business conditions, including factors impacting the Company's business in China such as pandemics and COVID-19; legislative and/or regulatory developments; Global Financial conditions, repatriation of profits or transfer of funds from China to Canada, operations in foreign jurisdictions and possible exposure to corruption, bribery or civil unrest; actions by regulators; uncertainties of investigations, proceedings or other types of claims and litigation; timing and completion of capital programs; liquidity and capital resources, negative operating cash flow and additional funding, dilution from further financing; financial performance and timing of capital; and other risks detailed from time to time in reports filed by Tenet with securities regulators in Canada. Reference should also be made to Management's Discussion and Analysis (MD&A) in Tenet's annual and interim reports, Annual Information Form, filed with Canadian securities regulators and available via the System for Electronic Document Analysis and Retrieval (SEDAR+) under Tenet's profile at for a description of major risk factors relating to Tenet. Although Tenet has attempted to identify certain factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Forward-looking statements reflect information as of the date on which they are made. The Company assumes no obligation to update or revise forward-looking statements to reflect future events, changes in circumstances, or changes in beliefs, unless required by applicable securities laws. In the event the Company does update any forward-looking statement, no inference should be made that the Company will make additional updates with respect to that statement, related matters, or any other forward-looking statement. Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. To view the source version of this press release, please visit
Yahoo
22 minutes ago
- Yahoo
Canada to join major European rearmament deal as early as June 23: sources
Prime Minister Mark Carney plans on joining a sweeping European plan in Belgium this month to rearm the continent and provide more military aid to Ukraine, CBC News has learned. Last month, Carney signalled to CBC's Power & Politics that he hopes to sign on to the new defence initiative by Canada Day as he tries to move away from relying on the United States for weapons and munitions. Now sources with knowledge of the matter say Carney is expected to join the rearmament deal as early as June 23, when he meets with European leaders in Brussels at the EU-Canada summit. Carney hinted on Monday this summit will "be more important than ever." "Canada will arrive at this summit with a plan to lead, with new investments to build our strength in service of our values," Carney said. WATCH | Why ReArm Europe would want Canada: The prime minister has said he's been in talks with European countries for months about closer defence co-operation. Carney wants to build up Canada's defence capabilities and expand its military suppliers beyond the U.S. as President Donald Trump wages a trade war on Canada and most of the world. "Over 75 cents on every dollar of capital spending for defence goes to the United States. That's not smart," Carney told Power & Politics host David Cochrane on May 27. Carney said it would be better to "spend more at home" with "diversified partnerships." CBC News is not naming the sources because they were not authorized to speak publicly about the deal. European Union President Ursula von der Leyen first proposed the plan called ReArm Europe in March to bolster the continent's military capabilities during global threats, Russia's ongoing invasion in Ukraine and uncertainty with the United States. The plan, renamed Readiness 2030, includes boosting European defence spending by up to 800 billion euros, including a 150-billion euro loan program to pay for more military technology and weapons. It's unclear how much money Canada would contribute. CBC News asked the Prime Minister's Office for details about the spending commitment and has yet to receive a response. Carney announced more than $9 billion in new military spending this fiscal year on Monday — and said Canada must further increase defence spending in the years to come. Once Canada joins the European deal, the government will have to decide what initiative it wants to launch and which countries it will partner with. The list of potential projects includes air and missile defence, drones and anti-drone systems, artificial intelligence and electronic warfare. "The first step is joining the club. The next step is deciding what projects you want to work on with other club members," said Dave Perry, president of the Canadian Global Affairs Institute. Ahead of the EU-Canada summit, Carney is also expected to announce more support for Ukraine. As part of Carney's promise to increase defence spending this year, supplementary estimates this week show the government has earmarked $2 billion for military aid to Ukraine and to expand defence partnerships. A source told CBC News the government is expected to reveal how much of that money will go toward Ukraine at the G7 meeting in in Kananaskis, Alta., next week. Carney is hosting this year's summit and invited Ukrainian president Volodymyr Zelenskyy, who hopes to urge Trump to move forward with a stronger sanctions package on Russia. WATCH | Carney says Three years into Russia's full-scale invasion of Ukraine, it continues to push forward in the Donbas region where Ukrainians are progressively losing "more and more" territory, Perry said. Ukraine needs armoured vehicles, artillery systems, ground-based air defence systems and munitions, he said. "They need help repairing all of the critical infrastructure the Russians are going after," he said. "They need the funding to basically keep the government of Ukraine solvent … they need a whole range of things."
Bloomberg
23 minutes ago
- Bloomberg
US Opposes European Push to Lower G-7 Price Cap on Russian Oil
The US isn't budging from its opposition to a lower price cap on Russian oil sales, people familiar with the matter said, dampening European hopes that leaders meeting for a Group of Seven summit in Canada will agree to a cut. A final decision rests with President Donald Trump and officials haven't lost all hope, according to the people, who asked not to be identified discussing private deliberations. But so far there's no movement from the position that the US spelled out at a meeting of G-7 finance ministers earlier this year, they said.
